IXICO plc (PHYOF)

Market Cap	24.35M +64.5%
Revenue (ttm)	9.61M +13.0%
Net Income	-2.40M
EPS	-0.03
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200
Open	0.0700
Previous Close	0.1500
Day's Range	0.0700 - 0.0700
52-Week Range	0.0700 - 0.1500
Beta	0.13
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 18, 2026

About IXICO

IXICO plc provides data analytics services to biopharmaceutical industry in the United States, the United Kingdom, the Netherlands, Denmark, Switzerland, Ireland, Europe, and internationally. The company offers collection, analysis, management, and reporting on gathered clinical study data; neurological diseases data collection and analysis; and sales and marketing services. It also provides imaging contract research organization solutions, including imaging biomarkers, such as radiological reads, volumetric MRI, PET and SPECT, and advanced MRI...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1995
• Employees: 79
• Stock Exchange: OTCMKTS
• Ticker Symbol: PHYOF

Financial Performance

In fiscal year 2025, IXICO's revenue was 6.53 million, an increase of 13.32% compared to the previous year's 5.77 million. Losses were -1.65 million, -17.49% less than in 2024.

Financial numbers in GBP

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 27, 2026

Data Sources Report a data error